CCL2 and Alzheimer disease: In addition to increased MCP-1 expression observed in the brain tissue [22], both serum and cerebrospinal fluid (CSF) levels of MCP-1 are significantly elevated in patients with mild cognitive impairment (MCI) and mild AD [23,24,25].